Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins

A general parametric approach to the meta‐analysis of randomized clinical trials

Anne Whitehead, John Whitehead · Statistics in Medicine · 1991 · 763 citations

Public Health, Biostatistics, Clinical Epidemiology +9

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

Henk J. Out, Bernadette Mannaerts, Stefan Driessen et al. · Human Reproduction · 1995 · 214 citations

Medicine, Endocrinology, Gynecology +17

Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis

Salim Daya, Joanne Gunby, Edward G. Hughes et al. · Fertility and Sterility · 1995 · 159 citations

Veterinary Medicine, Gynecology, Obstetrics +14

Relationship between embryo morphology and implantation rate after in vitro fertilization treatment in conception cycles

Adrian Shulman, Isaac Ben‐Nun, Yehudit Ghetler et al. · Fertility and Sterility · 1993 · 93 citations

Veterinary Medicine, Gynecology, Obstetrics +17

Efficacy and safety of recombinant follicle stimulating hormone (Puregon®) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial

B. Hédon, Henk J. Out, Jean‐Noël Hugues et al. · Human Reproduction · 1995 · 56 citations

Veterinary Medicine, Endocrinology, Gynecology +16